| 000 | 01360 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250515205032.0 | ||
| 264 | 0 | _c20101207 | |
| 008 | 201012s 0 0 eng d | ||
| 022 | _a1569-8041 | ||
| 024 | 7 |
_a10.1093/annonc/mdq009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aReddy, N | |
| 245 | 0 | 0 |
_aEnhancing activity and overcoming chemoresistance in hematologic malignancies with bortezomib: preclinical mechanistic studies. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cSep 2010 |
||
| 300 |
_a1756-1764 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBoronic Acids _xtherapeutic use |
| 650 | 0 | 4 | _aBortezomib |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
| 650 | 0 | 4 |
_aHematologic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPyrazines _xtherapeutic use |
| 700 | 1 | _aCzuczman, M S | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 21 _gno. 9 _gp. 1756-1764 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdq009 _zAvailable from publisher's website |
| 999 |
_c19505086 _d19505086 |
||